Rapport Therapeutics, Inc. (RAPP) stock
RAPPNasdaqPharmaceutical PreparationsFiscal year ends December 31
$26.15+0.30 (+1.16%)
Close on Nov 13, 2026Market cap $1.25BP/E –Yield –
Rapport Therapeutics total assets
Total assets on the balance sheet at the end of each period.
Rapport Therapeutics's total assets was $418.56M at Sep 30, 2026. For fiscal 2025 it was $512.43M, up 62.7% from the year before.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $512.43M | +62.7% |
| FY2024 | Dec 31, 2024 | $314.93M | +102.6% |
| FY2023 | Dec 31, 2023 | $155.42M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $418.56M | -21.8% |
| Q2 FY2026 | Jun 30, 2026 | $458.98M | +60.8% |
| Q1 FY2026 | Mar 31, 2026 | $497.60M | +64.7% |
| Q4 FY2025 | Dec 31, 2025 | $512.43M | +62.7% |
| Q3 FY2025 | Sep 30, 2025 | $535.32M | +61.7% |
| Q2 FY2025 | Jun 30, 2025 | $285.50M | -17.5% |
| Q1 FY2025 | Mar 31, 2025 | $302.05M | +94.3% |
| Q4 FY2024 | Dec 31, 2024 | $314.93M | – |
| Q3 FY2024 | Sep 30, 2024 | $331.14M | – |
| Q2 FY2024 | Jun 30, 2024 | $346.10M | – |
| Q4 FY2023 | Dec 31, 2023 | $155.42M | – |
See a number that looks wrong?